Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01891617 · ClinicalTrials.gov registry record · NA
Exercise Effects on Insulin, Gut Peptides, and Appetite
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01891617 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 16 participants.
The verdict
NCT01891617, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Determine whether the mid-day suppression of hunger and amplified increase in the release of glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide 1 (GLP-1) following morning exercise is due to increased fat content of the diet per se or a combination of high fat diet after morning exercise. The action of gut peptides, particularly GLP-1, on gastric emptying is likely to be important in mediating its effects on postprandial appetite and glycemia (Nauck et al. 1997). Our hypothesis is that exercise amplifies gut peptide secretion when diet is enriched with fat, and that this stimulus suppresses the hunger sensation.
Interventions
- OTHER Exercise and diets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01891617
The ClinicalTrials.gov registry entry for NCT01891617 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise and diets is the first listed.
NCT01891617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01891617 about?
NCT01891617 is a clinical study titled "Exercise Effects on Insulin, Gut Peptides, and Appetite". Determine whether the mid-day suppression of hunger and amplified increase in the release of glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide 1 (GLP-1) following morning exercise is due to increased fat content of the diet per se or a combination of high fat diet after mornin...
What is the current status of trial NCT01891617?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2010-11. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01891617?
The interventions under investigation include: Exercise and diets (OTHER).
Who is sponsoring clinical trial NCT01891617?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.